MTRI

Mentari Therapeutics, Inc. (MTRI)

Healthcare • NASDAQ • $19.87+6.83%

Key Fundamentals
Symbol
MTRI
Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology
Price
$19.87
Daily Change
+6.83%
Market Cap
$1.08B
Trailing P/E
N/A
Forward P/E
N/A
52W High
$23.30
52W Low
$5.75
Analyst Target
N/A
Dividend Yield
0.00%
Beta
N/A
About Mentari Therapeutics, Inc.

Mentari Therapeutics, Inc., a biotechnology company, develops and provides therapies for migraine prevention. The company's products include MT-001, an anti-PACAP monoclonal antibody designed for convenient subcutaneous dosing; MT-002, an anti-CGRP; and anti-PACAP bispecific antibody designed to inhibit these complementary pathways. The company was incorporated in 2025 and is based in Sacramento, California.

Company website

Research MTRI on Stk-Ai

Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.

Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.

Not financial advice. Pricing · Terms · Privacy · ·

Loading...